...
首页> 外文期刊>The journal of clinical psychiatry >Incidence of tardive dyskinesia with atypical versus conventional antipsychotic medications: a prospective cohort study.
【24h】

Incidence of tardive dyskinesia with atypical versus conventional antipsychotic medications: a prospective cohort study.

机译:非典型抗精神病药与传统抗精神病药的迟发性运动障碍发生率:一项前瞻性队列研究。

获取原文
获取原文并翻译 | 示例

摘要

OBJECTIVE: Most previous studies of the incidence of tardive dyskinesia with atypical antipsychotics compared with conventional antipsychotics have not had tardive dyskinesia as their primary focus. The current study aimed to compare the incidence of tardive dyskinesia with atypical vs conventional antipsychotics using methods similar to those from a previous prospective cohort study at our site in the 1980s. METHOD: Three hundred fifty-two initially tardive dyskinesia-free psychiatric outpatients (diagnosed at baseline using the Structured Clinical Interview for DSM-IV) were examined for a new diagnosis of tardive dyskinesia (using the Abnormal Involuntary Movement Scale and Glazer-Morgenstern criteria) every 6 months for up to 4 years at a community mental health center. At baseline, subjects were receiving conventional antipsychotics only (23%), atypicals only (64%), or both (14%). Only 26 subjects had never received conventional antipsychotics. Baseline evaluations were conducted from November 2000 through May 2003. Follow-ups were conducted through February 2005. RESULTS: Compared with subjects treated with conventional antipsychotics alone since the previous visit, the adjusted tardive dyskinesia incidence rate-ratio for subjects treated with atypical antipsychotics alone was 0.68 (95% CI, 0.29-1.64). The incidence and prevalence of tardive dyskinesia was similar to previous findings at this site in the 1980s. CONCLUSIONS: The incidence of tardive dyskinesia with recent exposure to atypical antipsychotics alone was more similar to that for conventional antipsychotics than in most previous studies. Despite high penetration of atypical antipsychotics into clinical practice, the incidence and prevalence of tardive dyskinesia appeared relatively unchanged since the 1980s. Clinicians should continue to monitor for tardive dyskinesia, and researchers should continue to pursue efforts to treat or prevent it.
机译:目的:以往关于非典型抗精神病药与传统抗精神病药相比迟发性运动障碍发生率的大多数研究都没有以迟发性运动障碍为主要研究对象。当前的研究旨在使用与1980年代以前在我们站点进行的前瞻性队列研究相似的方法,比较迟发性运动障碍与非典型抗精神病药和常规抗精神病药的发生率。方法:检查了三百零二名最初无迟发性运动障碍的精神科门诊患者(使用DSM-IV的结构化临床访谈在基线时进行了诊断),以诊断出迟发性运动障碍的新诊断(使用了非自愿运动量表和Glazer-Morgenstern标准)在社区心理健康中心每6个月(最多4年)。在基线时,受试者仅接受常规抗精神病药(23%),仅接受非典型抗精神病药(64%)或两者(14%)。只有26位受试者从未接受过常规抗精神病药物治疗。从2000年11月至2003年5月进行了基线评估。直到2005年2月进行了随访。结果:与上次访问以来仅接受常规抗精神病药治疗的受试者相比,仅接受非典型抗精神病药治疗的受试者的迟发性运动障碍发生率比为0.68(95%CI,0.29-1.64)。迟发性运动障碍的发生率和患病率与1980年代该部位以前的发现相似。结论:仅在最近接触非典型抗精神病药的情况下,迟发性运动障碍的发生率与传统抗精神病药的发生率相比,大多数先前的研究更为相似。尽管非典型抗精神病药大量进入临床实践,但迟发性运动障碍的发生率和患病率自1980年代以来一直相对保持不变。临床医生应继续监测迟发性运动障碍,研究人员应继续努力治疗或预防它。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号